Compare Nasdaq100 ETF (QQQ) vs Stryker Corporation (SYK) Price & Performance

Nasdaq100 ETFTrade

Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Nasdaq100 ETF vs Stryker Corporation — how do they compare? Nasdaq100 ETF trades at $704.97, while Stryker Corporation trades at $309.94 (market cap $120.60B). The key difference: Stryker Corporation pays a 1.12% dividend while Nasdaq100 ETF pays none, and Nasdaq100 ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.

	QQQ	SYK
52-Week High	$746.16	$403.53
52-Week Low	$553.88	$282.58
Market Cap	—	$120.60B
Sector	—	Technology
Enterprise Value	—	$132.36B
Dividend Yield	—	1.12%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Nasdaq100 ETF

QQQ trades at $708.97, up 1.96% over the past 24 hours, with technical indicators signaling a bearish trend overall despite a neutral oscillator reading. The ETF shows mixed analyst sentiment with a 50% buy and 50% sell consensus. Recent news highlights institutional position adjustments and comparisons with competing tech-focused ETFs.

Outlook remains divided; potential exists from tech sector strength and AI-driven growth, but risks include high concentration in tech stocks and market volatility. Investors should weigh the bearish technical signals against long-term growth prospects in the Nasdaq-100 index.

Stryker Corporation

Stryker (SYK) trades at $319.14, down 0.23% with a bearish technical signal despite strong fundamentals. The company reported $25.12B revenue and $3.25B net income for 2025, maintaining robust margins. Recent news highlights Mako RPS launch expansion in robotic surgery, while Q1 2026 earnings missed expectations due to a temporary cyber disruption, though full-year guidance remains unchanged.

Outlook remains positive with 74% analyst buy ratings and a $388.44 consensus price target implying 22% upside. Key risks include competitive pressures and execution challenges from recent cybersecurity issues. The stock presents a growth opportunity in med-tech innovation, trading below historical valuation multiples with healthy cash flow generation.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

QQQ

Equal-weighted ETFs gain attention as Q2 earnings growth broadens beyond tech giantsETF Trends · 13 hours agoBullish iShares Nasdaq Top 30 ETF outperforms QQQ with a 30% return by focusing on mega-cap tech giants.24/7 Wall Street · 3 days agoBullish REX AI Equity Premium Income ETF offers 36.5% yield but caps upside and may return capital.24/7 Wall Street · 4 days agoNeutral View details →

SYK

Robotic endoscopy devices market to grow at 10% CAGR, reaching $6.5B by 2034 driven by tech advances and rising GI disorders.Delveinsight · 4 hours agoBullish Global indocyanine green market to grow to $380M by 2031, driven by surgical imaging advances.PRNewsWire · 11 hours agoBullish View details →

About Nasdaq100 ETF

The ETF is designed to track the performance of the securities and the stocks in the NASDAQ-100 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.